Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
6.24
+0.13 (2.13%)
Oct 8, 2025, 2:21 PM EDT - Market open

Immuneering Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
39568215128426-
Upgrade
Market Cap Growth
314.56%-68.25%67.99%-69.91%--
Upgrade
Enterprise Value
3822212216267-
Upgrade
Last Close Price
6.112.207.354.8516.17-
Upgrade
PS Ratio
---404.05204.62-
Upgrade
PB Ratio
7.601.652.381.172.73-
Upgrade
P/TBV Ratio
18.471.992.581.252.86-
Upgrade
EV/Sales Ratio
---49.59128.17-
Upgrade
Debt / Equity Ratio
0.140.100.050.040.030.02
Upgrade
Asset Turnover
---0.000.020.09
Upgrade
Quick Ratio
3.524.8210.9213.1026.5316.66
Upgrade
Current Ratio
3.705.2811.3613.5027.0416.73
Upgrade
Return on Equity (ROE)
-130.47%-92.51%-53.36%-38.00%-35.00%-74.56%
Upgrade
Return on Assets (ROA)
-68.37%-51.57%-32.46%-22.38%-20.65%-40.66%
Upgrade
Return on Capital (ROIC)
-77.34%-56.97%-34.81%-23.43%-21.44%-42.85%
Upgrade
Earnings Yield
-15.35%-89.35%-24.86%-39.44%-7.88%-
Upgrade
FCF Yield
-12.73%-80.64%-22.92%-35.02%-7.26%-
Upgrade
Buyback Yield / Dilution
-12.61%-5.51%-7.69%-93.84%-175.00%0.00%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q